Cognitive Neurosciences has experienced much forward momentum since In Vivo last spoke to the Vancouver, Canada company about its innovative, culture- and language-agnostic cognitive assessment tool.
Driving improvements in early-stage diagnosis is the chief aim of technologies being developed for use in the dementia market, but...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?